Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-18T05:31:28.614Z Has data issue: false hasContentIssue false
  • English
  • Français

Long-term result of out-patient neodymium-doped yttrium aluminium garnet laser photocoagulation surgery for patients with epistaxis

Published online by Cambridge University Press:  24 November 2015

J Zhang ,
R Qiu  and
C Wei
J Zhang
Affiliation:
Department of Laser Surgery, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China
R Qiu
Affiliation:
Department of Laser Surgery, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China
C Wei*
Affiliation:
Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai, China
*
Address for correspondence: Dr Chunsheng Wei, Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Fudan University, Shanghai 200031, China E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To evaluate the long-term efficacy of out-patient neodymium-doped yttrium aluminium garnet laser photocoagulation surgery for patients with epistaxis.

Methods:

A retrospective clinical study was conducted. A total of 217 consecutive patients who presented with acute or recurrent epistaxis received neodymium-doped yttrium aluminium garnet laser photocoagulation treatment in an out-patient setting.

Results:

At three years, 94 per cent of acute epistaxis patients versus 88 per cent of recurrent epistaxis patients reported no bleeding. The outcome scores at 12 weeks and 3 years after treatment showed no significant differences between the 2 groups (p = 0.207 and p = 0.186). However, there was a significant difference in outcome scores at four weeks after treatment (p = 0.034). The median (and mean ± standard deviation) pain levels experienced during the laser operation (performed in an office setting) were 4.0 (3.75 ± 2.09) in the acute epistaxis group and 4.0 (3.83 ± 2.01) in the recurrent epistaxis group. Neither group had any complications.

Conclusion:

Neodymium-doped yttrium aluminium garnet laser photocoagulation is desirable in the treatment of both acute and recurrent epistaxis, and has long-lasting efficacy.

Keywords

LaserEpistaxisPhotocoagulation
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 130 , Issue 1 , January 2016 , pp. 76 - 81
Copyright
Copyright © JLO (1984) Limited 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Gifford, TO, Orlandi, RR. Epistaxis. Otolaryngol Clin North Am 2008;41:525–36CrossRefGoogle ScholarPubMed
2Watkinson, JC. Epistaxis. In: Mackay, IS, Bull, TR, eds. Scott-Brown's Otolaryngology, 6th edn, vol 4(18). London: Butterworths, 1997;5–7Google Scholar
3Krajina, A, Chrobok, V. Radiological diagnosis and management of epistaxis. Cardiovasc Intervent Radiol 2014;37:26–36CrossRefGoogle ScholarPubMed
4Pope, LE, Hobbs, CG. Epistaxis: an update on current management. Postgrad Med J 2005;81:309–14CrossRefGoogle ScholarPubMed
5Chiu, T, Dunn, JS. An anatomical study of the arteries of the anterior nasal septum. Otolaryngol Head Neck Surg 2006;134:33–6CrossRefGoogle ScholarPubMed
6Viehweg, TL, Roberson, JB, Hudson, JW. Epistaxis: diagnosis and treatment. J Oral Maxillofac Surg 2006;64:511–18CrossRefGoogle ScholarPubMed
7Zhang, J, Qiu, R. A prospective randomized controlled trial of Nd:YAG laser photocoagulation versus liquid paraffin plus antiseptic cream in the treatment of recurrent epistaxis. Clin Otolaryngol 2012;37:271–5CrossRefGoogle ScholarPubMed
8Bergler, W, Sadick, H, Gotte, K, Riedel, F, Hörmann, K. Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 2002;111(3 Pt 1):222–8CrossRefGoogle ScholarPubMed
9McGarry, G. Nosebleeds in children. Clin Evid 2006;15:496–9Google Scholar
10Burton, MJ, Doree, C. Interventions for recurrent idiopathic epistaxis (nosebleeds) in children. Cochrane Database Syst Rev 2004;(1):CD004461Google Scholar
11Murthy, P, Nilssen, EL, Rao, S, McClymont, LG. A randomised clinical trial of antiseptic nasal carrier cream and silver nitrate cautery in the treatment of recurrent anterior epistaxis. Clin Otolaryngol Allied Sci 1999;24:228–31CrossRefGoogle ScholarPubMed
12Hoag, JB, Terry, P, Mitchell, S, Reh, D, Merlo, CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 2010;120:838–43CrossRefGoogle ScholarPubMed
13Karapantzos, I, Tsimpiris, N, Goulis, DG, Van Hoecke, H, Van Cauwenberge, P, Danielides, V. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol 2005;262:830–3CrossRefGoogle ScholarPubMed
14Velegrakis, GA, Prokopakis, EP, Papadakis, CE, Helidonis, ES. Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia. J Otolaryngol 1997;26:384–6Google ScholarPubMed
15Mahoney, EJ, Shapshay, SM. Nd-YAG laser photocoagulation for epistaxis associated with hereditary hemorrhagic telangiectasia. Laryngoscope 2005;115:373–5CrossRefGoogle ScholarPubMed
16Shah, RK, Dhingra, JK, Shapshay, SM. Hereditary hemorrhagic telangiectasia: a review of 76 cases. Laryngoscope 2002;112:767–73CrossRefGoogle ScholarPubMed